Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 23 April 2012 | By Ansis Helmanis,
The Commission on Social Security and Family of the House of Representatives held on 19 April 2012 a public hearing to discuss the situation of Brazilian women with silicone breast implants made by now-defunct French manufacturer Poly Implant Prothese and Dutch manufacturer Rofil.
ANVISA's Chief Executive Officer, Dirceu Barbano, noted his agency had inspected two manufacturers and that by the end of this year all manufacturing plants with valid registration would be inspected by the agency.
The President of the Brazilian Society of Mastology, Carlos Ruiz, expressed his concern over the shortage of breast implants in the country, but underscored the importance of rigorous regulation of the implants.
Commission on Social Security and Family
More Breaking News from RegLink
Tags: Commission of Social Security and Family, Rofil, Breast Implant, PIP, brazil, medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.